Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Young

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|September 17, 2002
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of diseaseKathryn Anastos, Yolanda Barrón, Paolo Miotti, et al.
Journal of Lower Genital Tract Disease|December 31, 2010
Effect of stress and depression on the frequency of squamous intraepithelial lesionsL Stewart Massad, Denis Agniel, Howard Minkoff, et al.
Contemporary Clinical Trials|June 24, 2017
Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study resultsRobert L Cook, Kathleen M Weber, Dao Mai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failureStephen J Gange, Michael F Schneider, Robert M Grant, et al.
AIDS Patient Care and Stds|November 3, 2009
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS)Toni Frederick, Pamela Burian, Norah Terrault, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Enhanced immunogenicity of a <i>Clostridioides difficile</i> TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvantFarha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 9, 2006
Relation of stavudine discontinuation to anthropometric changes among HIV-infected womenPhyllis C Tien, Michael F Schneider, Stephen R Cole, et al.
NPJ Vaccines|February 18, 2025
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvantFarha Naz, Nicholas Hagspiel, Feifan Xu, et al.
AIDS (London, England)|April 11, 2006
Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestationsNiloufar Ameli, Peter Bacchetti, Rhoda Ashley Morrow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapyMichael N Neely, Lorie Benning, Jiaao Xu, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|September 17, 2002
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of diseaseKathryn Anastos, Yolanda Barrón, Paolo Miotti, et al.
Journal of Lower Genital Tract Disease|December 31, 2010
Effect of stress and depression on the frequency of squamous intraepithelial lesionsL Stewart Massad, Denis Agniel, Howard Minkoff, et al.
Contemporary Clinical Trials|June 24, 2017
Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study resultsRobert L Cook, Kathleen M Weber, Dao Mai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failureStephen J Gange, Michael F Schneider, Robert M Grant, et al.
AIDS Patient Care and Stds|November 3, 2009
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS)Toni Frederick, Pamela Burian, Norah Terrault, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Enhanced immunogenicity of a <i>Clostridioides difficile</i> TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvantFarha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 9, 2006
Relation of stavudine discontinuation to anthropometric changes among HIV-infected womenPhyllis C Tien, Michael F Schneider, Stephen R Cole, et al.
NPJ Vaccines|February 18, 2025
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvantFarha Naz, Nicholas Hagspiel, Feifan Xu, et al.
AIDS (London, England)|April 11, 2006
Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestationsNiloufar Ameli, Peter Bacchetti, Rhoda Ashley Morrow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapyMichael N Neely, Lorie Benning, Jiaao Xu, et al.
Pageof 17